Jpmorgan Chase & CO Sintx Technologies, Inc. Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.39 - $6828.0 $1,385 - $24.3 Million	-3,552 Reduced 94.34%	213 $0
Q2 2022 Aug 11, 2022	BUY	$0.38 - $0.64 $257 - $433	678 Added 21.96%	3,765 $2,000
Q1 2022 May 11, 2022	BUY	$0.43 - $0.71 $1,100 - $1,817	2,560 Added 485.77%	3,087 $2,000
Q4 2021 Feb 10, 2022	BUY	$0.62 - $1.32 $213 - $455	345 Added 189.56%	527 $0
Q3 2021 Nov 12, 2021	BUY	$1.24 - $1.76 $225 - $320	182 New	182 $0

Ticker SINT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,729,600
Market Cap $98.9M
Description
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and si...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.